Xuhui Central Hospital, Shanghai
16
4
4
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
6%
1 trials in Phase 3/4
40%
2 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)
Role: collaborator
Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer
Role: collaborator
The CT-based Deep Learning Model Predicts Complications in Partial Nephrectomy
Role: collaborator
Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers
Role: collaborator
Shengyu Decoction and Lijin Manipulation for Knee OA: 3D Gait Analysis
Role: lead
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
Role: collaborator
Effect of Electroacupuncture on Treating the First-episode Depression
Role: collaborator
Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC
Role: collaborator
Surgery for Masaoka-Koga I-II Thymoma
Role: collaborator
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
Role: collaborator
Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure
Role: collaborator
PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
Role: collaborator
Feasibility, Safety, and Outcomes of Intensive Enteral Nutrition in Patients With Mechanical Ventilation
Role: collaborator
A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis.
Role: lead
Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects
Role: collaborator
A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects
Role: collaborator
All 16 trials loaded